Advertisement

  • Loading metrics

Open Access

Correction

Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions

  • Marco A. Biamonte,
  • Paul T. Cantey,
  • Yaya I. Coulibaly,
  • Katherine M. Gass,
  • Louise C. Hamill,
  • Christopher Hanna,
  • Patrick J. Lammie,
  • Joseph Kamgno,
  • Thomas B. Nutman,
  • David W. Oguttu,
  • Dieudonné P. Sankara,
  • Wilma A. Stolk,
  • Thomas R. Unnasch

Point 5 of the section ‘Available diagnostic tools and their limitations’ incorrectly states that the BIOLINE Onchocerciasis IgG4 ELISA (Abbott) is discontinued. As of July 2023, the ELISA kit is still available, catalog number 61EK11.

Reference

  1. 1. Biamonte MA, Cantey PT, Coulibaly YI, Gass KM, Hamill LC, Hanna C, et al. (2022) Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions. PLoS Negl Trop Dis 16(8): e0010682. https://doi.org/10.1371/journal.pntd.0010682 pmid:35921329

Citation: Biamonte MA, Cantey PT, Coulibaly YI, Gass KM, Hamill LC, Hanna C, et al. (2023) Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions. PLoS Negl Trop Dis 17(7): e0011505. https://doi.org/10.1371/journal.pntd.0011505

Published: July 19, 2023

Copyright: © 2023 Biamonte et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.